Reconsidering low-dose aspirin therapy for cardiovascular disease: A study protocol for physician and patient behavioral change

Implementation Science

Volumn 6, Issue 1, 2011, Pages

  Folks, Brittany ^a   LeBlanc, William G ^a   Staton, Elizabeth W ^a   Pace, Wilson D ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; CLINICAL PROTOCOL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DECISION SUPPORT SYSTEM; HUMAN; MEDICAL EDUCATION; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL; UNITED STATES;

ASPIRIN; CARDIOVASCULAR DISEASES; CLINICAL PROTOCOLS; COLORADO; CORONARY ARTERY DISEASE; DECISION SUPPORT TECHNIQUES; EDUCATION, MEDICAL, CONTINUING; HUMANS; PHYSICIAN'S PRACTICE PATTERNS;

EID: 79959482482     PISSN: None     EISSN: 17485908     Source Type: Journal    
DOI: 10.1186/1748-5908-6-65     Document Type: Article

References (37)

1. Hayden M, Pignone M, Phillips C, Mulrow C. Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002, 136:161-172.
2. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998, 351:1755-1762. 10.1016/S0140-6736(98)04311-6, 9635947.
3. Peto R, Gray R, Collins R, Wheatley K, Hennekens C, Jamrozik K, Warlow C, Hafner B, Thompson E, Norton S, et al. Randomised trial of prophylactic daily aspirin in British male doctors. Br Med J (Clin Res Ed) 1988, 296:313-316.
4. Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, Hennekens CH, Buring JE. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005, 352:1293-1304. 10.1056/NEJMoa050613, 15753114.
5. Final report on the aspirin component of the ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group. N Engl J Med 1989, 321:129-135.
6. Anonymous Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework.[see comment]. Lancet 1998, 351:233-241. Anonymous.
7. Belch J, MacCuish A, Campbell I, Cobbe S, Taylor R, Prescott R, Lee R, Bancroft J, MacEwan S, Shepherd J, Macfarlane P, Morris A, Jung R, Kelly C, Connacher A, Peden N, Jamieson A, Matthews D, Leese G, McKnight J, O'Brien I, Semple C, Petrie J, Gordon D, Pringle S, MacWalter R. The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. BMJ 2008, 337:a1840. 10.1136/bmj.a1840, 2658865, 18927173.
8. Ogawa H, Nakayama M, Morimoto T, Uemura S, Kanauchi M, Doi N, Jinnouchi H, Sugiyama S, Saito Y. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial. JAMA 2008, 300:2134-2141. 10.1001/jama.2008.623, 18997198.
9. Sacco M, Pellegrini F, Roncaglioni MC, Avanzini F, Tognoni G, Nicolucci A. Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial. Diabetes Care 2003, 26:3264-3272. 10.2337/diacare.26.12.3264, 14633812.
10. Ethier J, Bragg-Gresham JL, Piera L, Akizawa T, Asano Y, Mason N, Gillespie BW, Young EW. Aspirin prescription and outcomes in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS).[see comment]. American Journal of Kidney Diseases 2007, 50:602-611. 10.1053/j.ajkd.2007.07.007, 17900460.
11. Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, Buring J, Hennekens C, Kearney P, Meade T, Patrono C, Roncaglioni MC, Zanchetti A. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009, 373:1849-1860. 10.1016/S0140-6736(09)60503-1, 2715005, 19482214.
12. Bartolucci AA, Howard G. Meta-analysis of data from the six primary prevention trials of cardiovascular events using aspirin. Am J Cardiol 2006, 98:746-750. 10.1016/j.amjcard.2006.04.012, 16950176.
13. Berger JS, Roncaglioni MC, Avanzini F, Pangrazzi I, Tognoni G, Brown DL. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA 2006, 295:306-313. 10.1001/jama.295.3.306, 16418466.
14. Patrono C, Garcia Rodriguez LA, Landolfi R, Baigent C. Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med 2005, 353:2373-2383. 10.1056/NEJMra052717, 16319386.
15. Fleming T, Nissen SE, Borer JS, Armstrong PW. Report from the 100th Cardiovascular and Renal Drugs Advisory Committee meeting: US Food and Drug Administration: December 8-9, 2003 Gaithersburg, MD. Circulation 2004, 109:e9004-9005.
16. Aspirin should it be used for primary prevention in diabetics?. , http://www.theheart.org/article/912299.do
17. Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, Culebras A, Degraba TJ, Gorelick PB, Guyton JR, Hart RG, Howard G, Kelly-Hayes M, Nixon JV, Sacco RL. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke 2006, 37:1583-1633.
18. Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009, 150:396-404.
19. Colwell JA. Aspirin therapy in diabetes. Diabetes Care 2003, 26(Suppl 1):S87-88.
20. Berenholtz S, Pronovost PJ. Barriers to translating evidence into practice. Curr Opin Crit Care 2003, 9:321-325. 10.1097/00075198-200308000-00012, 12883289.
21. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, Rubin HR. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999, 282:1458-1465. 10.1001/jama.282.15.1458, 10535437.
22. Gronseth GS. From evidence to action. NeuroRx 2004, 1:331-340. 534934, 15717035.
23. Poses RM. One size does not fit all: questions to answer before intervening to change physician behavior. Joint Commission Journal on Quality Improvement 1999, 25:486-495.
24. Sittig DF, Krall MA, Dykstra RH, Russell A, Chin HL. A survey of factors affecting clinician acceptance of clinical decision support. BMC Med Inform Decis Mak 2006, 6:6. 10.1186/1472-6947-6-6, 1403751, 16451720.
25. Bero LA, Grilli R, Grimshaw JM, Harvey E, Oxman AD, Thomson MA. Getting research findings into practice: Closing the gap between research and practice: An overview of systematic reviews of interventions to promote the implementation of research findings. BMJ 1998, 317:465-468. 1113716, 9703533.
26. Bloom BS. Effects of continuing medical education on improving physician clinical care and patient health: a review of systematic reviews. Int J Technol Assess Health Care 2005, 21:380-385.
27. Grimshaw JM, Eccles MP, Walker AE, Thomas RE. Changing physicians' behavior: what works and thoughts on getting more things to work. J Contin Educ Health Prof 2002, 22:237-243. 10.1002/chp.1340220408, 12613059.
28. Newton J, Knight D, Woolhead G. General practitioners and clinical guidelines: a survey of knowledge, use and beliefs. Br J Gen Pract 1996, 46:513-517. 1239745, 8917869.
29. Siriwardena AN. Clinical guidelines in primary care: a survey of general practitioners' attitudes and behaviour. Br J Gen Pract 1995, 45:643-647. 1239465, 8745861.
30. Smith WR. Evidence for the effectiveness of techniques To change physician behavior. Chest 2000, 118:8S-17S. 10.1378/chest.118.2_suppl.8S, 10939994.
31. Elson RB, Connelly DP. Computerized patient records in primary care. Their role in mediating guideline-driven physician behavior change. Arch Fam Med 1995, 4:698-705. 10.1001/archfami.4.8.698, 7620600.
32. Johnston ME, Langton KB, Haynes RB, Mathieu A. Effects of computer-based clinical decision support systems on clinician performance and patient outcome. A critical appraisal of research. Ann Intern Med 1994, 120:135-142.
33. Austin SM, Balas EA, Mitchell JA, Ewigman BG. Effect of physician reminders on preventive care: meta-analysis of randomized clinical trials. Proc Annu Symp Comput Appl Med Care 1994, 121-124.
34. Davis DA, Taylor-Vaisey A. Translating guidelines into practice. A systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines. CMAJ 1997, 157:408-416. 1227916, 9275952.
35. Shea S, DuMouchel W, Bahamonde L. A meta-analysis of 16 randomized controlled trials to evaluate computer-based clinical reminder systems for preventive care in the ambulatory setting. Journal of the American Medical Informatics Association 1996, 3:399-409. 10.1136/jamia.1996.97084513, 116324, 8930856.
36. Oxman AD, Thomson MA, Davis DA, Haynes RB. No magic bullets: a systematic review of 102 trials of interventions to improve professional practice. CMAJ 1995, 153:1423-1431. 1487455, 7585368.
37. D'Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008, 117:743-753. 10.1161/CIRCULATIONAHA.107.699579, 18212285.